Telmisartan/amlodipine
Combination of | |
---|---|
Telmisartan | Angiotensin II receptor antagonist |
Amlodipine | Calcium channel blocker |
Clinical data | |
Trade names | Twynsta, others |
License data | |
Routes of administration | By mouth |
ATC code | |
Legal status | |
Legal status | |
Identifiers | |
CAS Number | |
KEGG |
Telmisartan/amlodipine, sold under the brand name Twynsta among others, is a fixed-dose combination medication used to treat high blood pressure.[3] It is a combination of telmisartan, an angiotensin II receptor antagonist; and amlodipine, as the besilate, a calcium channel blocker.[3] It is taken by mouth.[3]
Common side effects include dizziness, swelling, and back pain.[3] Severe side effects may include low blood pressure, kidney problems, electrolyte problems, and a heart attack.[3] Use during pregnancy may harm the baby.[3] Telmisartan works by blocking the effects of angiotensin II while amlodipine works by decreasing calcium ion entry into smooth muscle and heart muscle.[3]
The combination was approved for medical use in the United States in 2009.[3] The combination is on the World Health Organization's List of Essential Medicines.[5] It is available as a generic medication.[6]
References
[edit]- ^ "Prescription medicines: registration of new generic medicines and biosimilar medicines, 2017". Therapeutic Goods Administration (TGA). 21 June 2022. Retrieved 30 March 2024.
- ^ "Twynsta Product information". Health Canada. 11 August 2011. Retrieved 17 February 2025.
- ^ a b c d e f g h i "DailyMed - Telmisartan and Amlodipine tablet". DailyMed. Retrieved 30 October 2019.
- ^ "Twynsta (telmisartan/amlodipine) tablets, for oral use Initial U.S. Approval: 2009". DailyMed. Retrieved 18 March 2023.
- ^ World Health Organization (2023). The selection and use of essential medicines 2023: web annex A: World Health Organization model list of essential medicines: 23rd list (2023). Geneva: World Health Organization. hdl:10665/371090. WHO/MHP/HPS/EML/2023.02.
- ^ "Telmisartan and Amlodipine (Professional Patient Advice)". Drugs.com. Retrieved 30 October 2019.